Showing results (61-70 of 212) with videos related to

Sort By:
Pageof 22
Cancer Cell|March 24, 2012
Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinomaPaolo P Provenzano, Carlos Cuevas, Amy E Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2017
Pancreatic Cancer: "A Riddle Wrapped in a Mystery inside an Enigma"Erkut Borazanci, Chi V Dang, Robert W Robey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2004
American Society of Clinical Oncology Technology Assessment: chemotherapy sensitivity and resistance assaysDeborah Schrag, Harinder S Garewal, Harold J Burstein, et al.
Journal of Cancer|January 3, 2012
Progression-free Survival Decreases with Each Subsequent Therapy in Patients Presenting for Phase I Clinical TrialsChristopher H Bailey, Gayle Jameson, Chao Sima, et al.
Dermatology Reports|November 12, 2014
Long-term safety, tolerability, and efficacy of vismodegib in two patients with metastatic basal cell carcinoma and basal cell nevus syndromeGlen J Weiss, Raoul Tibes, Lisa Blaydorn, et al.
Molecular Cancer Therapeutics|March 27, 2003
Targeting aurora2 kinase in oncogenesis: a structural bioinformatics approach to target validation and rational drug designHariprasad Vankayalapati, David J Bearss, José W Saldanha, et al.
Research Square|September 18, 2023
Tumor Response to Stroma-Modifying Therapy: Magnetic Resonance Imaging Findings in Early-Phase Clinical Trials of Pegvorhyaluronidase alpha (PEGPH20)Andrés M Arias-Lorza, James R Costello, Sunil R Hingorani, et al.
Molecular Cancer Therapeutics|October 17, 2006
Comparing Aurora A and Aurora B as molecular targets for growth inhibition of pancreatic cancer cellsSteven L Warner, Ruben M Munoz, Phillip Stafford, et al.
Molecular Cancer Therapeutics|May 14, 2004
Identification of human polo-like kinase 1 as a potential therapeutic target in pancreatic cancerPhillip J Gray, David J Bearss, Haiyong Han, et al.
Scientific Reports|May 21, 2024
Magnetic resonance imaging of tumor response to stroma-modifying pegvorhyaluronidase alpha (PEGPH20) therapy in early-phase clinical trialsAndrés M Arias-Lorza, James R Costello, Sunil R Hingorani, et al.
Pageof 22